PTCB Exam Prep 2022-2023 Exam 1
Questions With Complete Solutions.
Which lof lthe lfollowing lis lfalse labout lthe lchemical lname lof la ldrug?
a. lIt lis lalso lcalled lthe lscientific lname
b. lIt lis lused lin lconventional llanguage
c. lThe lmost limportant lnaming lsystem lis lthe lIUPAC lname
d. lDrugs lare lnamed laccording lto lthe lstructure lof lthe ldrug lmolecules l- lcorrect lanswer. l l l lB.
lIt lis lused lin lconventional llanguage
Which lof lthe lfollowing lis la lgeneric lname?
a. lPenicillin
b. lAdvil
c. lN-acetyl-p-aminophenol
d. lZoloft l- lcorrect lanswer. l l l lA. lPenicillin
Which lof lthe lfollowing lis lanother lname lfor lthe lbrand lname lof la ldrug?
a. lProprietary lname
b. lScientific lname
c. lTrademark lname
d. lCopyright lname l- lcorrect lanswer. l l l lC. lTrademark lname
According lto lthe lATC lsystem, llevel l1 lclassifies ldrugs laccording lto l____
a. lTherapeutic laction
b. lOrgan lsystems
c. lMechanism lof laction
d. lChemical lproperties l- lcorrect lanswer. l l l lB. lOrgan lsystems
Which lof lthe lfollowing llevels lof lthe lATC lsystem lclassifies ldrugs laccording lto lchemical
lcomponents?
a. lLevel l2
, b. lLevel l3
c. lLevel l4
d. lLevel l5 l- lcorrect lanswer. l l l lD. lLevel l5
Drugs lwith lno lrisk lof lteratogenicity lare lgrouped linto lwhich lof lthe lfollowing lcategories?
a. lCategory lX
b. lCategory lN
c. lCategory lA
d. lCategory lD l- lcorrect lanswer. l l l lC. lCategory lA
Which lof lthe lfollowing lpregnancy lcategories ldescribes ldrugs lthat lhave lnot lyet lbeen
lcategorized lby lthe lFDA? l
a. lCategory lX
b. lCategory lN
c. lCategory lA
d. lCategory lD l- lcorrect lanswer. l l l lB. lCategory lN
Which lof lthe lfollowing lfalse labout lschedule lI ldrugs?
a. lThey lhave la lhigh lpotential lfor labuse land laddiction
b. lThey lare lsafe lfor lmedical luse lonly lunder lstrict lmedical lsupervision
c. lHeroin lis lan lexample
d. lPsilocybin lis lan lexample l- lcorrect lanswer. l l l lB. lThey lare lsafe lfor lmedical luse lonly lunder
lstrict lmedical lsupervision
Which lof lthe lfollowing lis la lschedule lII ldrug?
a. lMescaline
b. lCathinone
c. lPhencyclidine
d. lKetamine l- lcorrect lanswer. l l l lC. lPhencyclidine
Concerning lLASA lmedications, lwhat lis lthe lmost lappropriate ldescription?
a. lMedications lthat lhave lsimilarities lin lshape lonly
b. lMedications lthat lhave lsimilarities lin lname lonly
c. lMedications lthat lappear lsimilar lin lchemical lproperties
d. lMedications lthat lare lsimilar lin lphysical lstructure, lpackaging land ldrug lnames lwith
lsimilar lspellings lor lpronunciation l- lcorrect lanswer. l l l lD. lMedications lthat lare lsimilar lin
lphysical lstructure, lpackaging land ldrug lnames lwith lsimilar lspellings lor lpronunciation
Which lof lthe lfollowing lis lnot la lrisk lfactor lassociated lwith lLASA lmedications?
a. lIllegible lwriting l
b. lIncomplete lknowledge lof ldrug lnames
c. lMedications lwith ldifferent lclinical luses
d. lSimilar lpackaging land llabel l- lcorrect lanswer. l l l lC. lMedications lwith ldifferent lclinical
luses
Questions With Complete Solutions.
Which lof lthe lfollowing lis lfalse labout lthe lchemical lname lof la ldrug?
a. lIt lis lalso lcalled lthe lscientific lname
b. lIt lis lused lin lconventional llanguage
c. lThe lmost limportant lnaming lsystem lis lthe lIUPAC lname
d. lDrugs lare lnamed laccording lto lthe lstructure lof lthe ldrug lmolecules l- lcorrect lanswer. l l l lB.
lIt lis lused lin lconventional llanguage
Which lof lthe lfollowing lis la lgeneric lname?
a. lPenicillin
b. lAdvil
c. lN-acetyl-p-aminophenol
d. lZoloft l- lcorrect lanswer. l l l lA. lPenicillin
Which lof lthe lfollowing lis lanother lname lfor lthe lbrand lname lof la ldrug?
a. lProprietary lname
b. lScientific lname
c. lTrademark lname
d. lCopyright lname l- lcorrect lanswer. l l l lC. lTrademark lname
According lto lthe lATC lsystem, llevel l1 lclassifies ldrugs laccording lto l____
a. lTherapeutic laction
b. lOrgan lsystems
c. lMechanism lof laction
d. lChemical lproperties l- lcorrect lanswer. l l l lB. lOrgan lsystems
Which lof lthe lfollowing llevels lof lthe lATC lsystem lclassifies ldrugs laccording lto lchemical
lcomponents?
a. lLevel l2
, b. lLevel l3
c. lLevel l4
d. lLevel l5 l- lcorrect lanswer. l l l lD. lLevel l5
Drugs lwith lno lrisk lof lteratogenicity lare lgrouped linto lwhich lof lthe lfollowing lcategories?
a. lCategory lX
b. lCategory lN
c. lCategory lA
d. lCategory lD l- lcorrect lanswer. l l l lC. lCategory lA
Which lof lthe lfollowing lpregnancy lcategories ldescribes ldrugs lthat lhave lnot lyet lbeen
lcategorized lby lthe lFDA? l
a. lCategory lX
b. lCategory lN
c. lCategory lA
d. lCategory lD l- lcorrect lanswer. l l l lB. lCategory lN
Which lof lthe lfollowing lfalse labout lschedule lI ldrugs?
a. lThey lhave la lhigh lpotential lfor labuse land laddiction
b. lThey lare lsafe lfor lmedical luse lonly lunder lstrict lmedical lsupervision
c. lHeroin lis lan lexample
d. lPsilocybin lis lan lexample l- lcorrect lanswer. l l l lB. lThey lare lsafe lfor lmedical luse lonly lunder
lstrict lmedical lsupervision
Which lof lthe lfollowing lis la lschedule lII ldrug?
a. lMescaline
b. lCathinone
c. lPhencyclidine
d. lKetamine l- lcorrect lanswer. l l l lC. lPhencyclidine
Concerning lLASA lmedications, lwhat lis lthe lmost lappropriate ldescription?
a. lMedications lthat lhave lsimilarities lin lshape lonly
b. lMedications lthat lhave lsimilarities lin lname lonly
c. lMedications lthat lappear lsimilar lin lchemical lproperties
d. lMedications lthat lare lsimilar lin lphysical lstructure, lpackaging land ldrug lnames lwith
lsimilar lspellings lor lpronunciation l- lcorrect lanswer. l l l lD. lMedications lthat lare lsimilar lin
lphysical lstructure, lpackaging land ldrug lnames lwith lsimilar lspellings lor lpronunciation
Which lof lthe lfollowing lis lnot la lrisk lfactor lassociated lwith lLASA lmedications?
a. lIllegible lwriting l
b. lIncomplete lknowledge lof ldrug lnames
c. lMedications lwith ldifferent lclinical luses
d. lSimilar lpackaging land llabel l- lcorrect lanswer. l l l lC. lMedications lwith ldifferent lclinical
luses
